# Cerebral Microembolism in the Critically Ill With Acute Kidney Injury

> **NCT02621749** · NA · TERMINATED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 66 (actual)

## Conditions studied

- Cerebral Embolism

## Interventions

- **DEVICE:** Renal replacement therapy

## Key facts

- **NCT ID:** NCT02621749
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-01
- **Primary completion:** 2022-11-06
- **Final completion:** 2022-11-06
- **Target enrollment:** 66 (ACTUAL)
- **Why stopped:** Futility
- **Last updated:** 2022-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02621749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02621749, "Cerebral Microembolism in the Critically Ill With Acute Kidney Injury". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02621749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*